Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) has shared an announcement.
Neuroscientific Biopharmaceuticals Ltd announced the cessation of 3,000,000 options that were set to expire on December 7, 2024, without being exercised or converted. This update on the company’s issued capital reflects a strategic adjustment, potentially impacting stakeholders’ perceptions of the company’s financial maneuvers and its future securities management.
More about Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd operates in the biopharmaceutical industry, focusing on the development of novel drugs aimed at treating neurological disorders. The company is dedicated to innovative research with a specific market focus on addressing unmet medical needs in neuroscience.
YTD Price Performance: 26.67%
Average Trading Volume: 131,973
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$5.49M
See more insights into NSB stock on TipRanks’ Stock Analysis page.
